Update on imatinib for gastrointestinal stromal tumors: duration of treatment. | Onco Targets Ther;6: 1011-23, 2013. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Update on imatinib for gastrointestinal stromal tumors: duration of treatment.

Linch, Mark; Claus, Jeroen; Benson, Charlotte.

Affiliation

Linch M; Sarcoma Unit, Royal Marsden Hospital, United Kingdom ; Protein Phosphorylation Laboratory, Cancer Research UK London Research Institute, London, United Kingdom.

Onco Targets Ther ; 6: 1011-23, 2013.

Article in En | MEDLINE | ID: mdl-23935374

Key words

adjuvant; c-KIT; gastrointestinal stromal tumors; imatinib; mutations; resistance; treatment

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Onco Targets Ther Year: 2013 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Onco Targets Ther Year: 2013 Document type: Article Affiliation country: